05 July 2018 | News
The agreement has been signed to identify new drug candidates for treatment of drug resistant infections.
Image credit- quora.com
Zydus Cadila has inked an agreement with Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (IMTECH) to identify new drug candidates for treatment of drug resistant infections.
The collaborative research agreement will see scientists from both organisations working together on microbiology and genomics to identify new lead candidate as novel anti-tuberculosis compound.
For this project, scientists at IMTECH will utilise their expertise and scientific knowledge in microbiology while Zydus Cadila will provide expertise in medicinal chemistry and pharmaceutical drug development to develop new drug combinations against drug-resistant pathogens which causes severe diseases in India and across the world.